DOI:
10.1055/s-00000021
Gesundheitsökonomie & Qualitätsmanagement
LinksClose Window
References
Anell A.
Priority setting for pharmaceuticals. The use of health economic evidence by reimbursement and clinical guidance committees.
The European Journal of Health Economics 2004; 5 (1): 28-35
We do not assume any responsibility for the contents of the web pages of other providers.